Welcome to the Bahria University DSpace digital repository. DSpace is a digital service that collects, preserves, and distributes digital material. Repositories are important tools for preserving an organization's legacy; they facilitate digital preservation and scholarly communication.
dc.contributor.author | Hafiza Tuseef Sayyar | |
dc.contributor.author | Afshan Siddiq | |
dc.date.accessioned | 2020-07-24T08:31:58Z | |
dc.date.available | 2020-07-24T08:31:58Z | |
dc.date.issued | 2020-07-01 | |
dc.identifier.issn | 2220-7562 | |
dc.identifier.uri | http://hdl.handle.net/123456789/9339 | |
dc.description.abstract | Schizophrenia is a disorder of mental debility characterized by abnormal social behavior in which person is unable to recognize reality. The sign and symptoms are variable and heterogeneous. Due to the diverse symptoms and variable treatment response, it is challenging to treat. Recent advancements in genomic, epidemiology and neurosciences can provide the appropriate medicines and treatments for minimizing symptoms and consequences of schizophrenia. This literature review was highlights the etiology, pathophysiology, neurotransmitter system, novel treatment and management of schizophrenia.The mainstay treatment of schizophrenic patients included antipsychotic drug with psychotherapy, social rehabilitation and job training | en_US |
dc.description.sponsorship | JBUMDC | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bahria University Medical and Dental College Karachi | en_US |
dc.relation.ispartofseries | 10;03 | |
dc.subject | Antipsychotic drug, Schizophrenia, Pathophysiology, Neurotransmitter system | en_US |
dc.title | Pharmacologic Advancement in Schizophrenia | en_US |
dc.type | Article | en_US |